Breaking News, Collaborations & Alliances

Nuclidium, PharmaLogic Partner for Sustainable Development of Copper-based Theranostics

Collaboration agreement strengthens Cu-supply chain capabilities for clinical development in North America.

Nuclidium and PharmaLogic Holdings entered into a collaboration agreement for the production and clinical supply of copper (Cu) in the U.S. to accelerate the development of Nuclidium’s theranostic pipeline. By combining copper radiometals with highly specific cancer-targeting molecules, Nuclidium’s theranostic approach aims to offer innovative diagnostic and therapeutic treatments for patients suffering from a range of solid tumors. The partnership with PharmaLogic will provide Nu...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters